Vincristine Sulphate Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1 mg/10 mL (0.1 mg/mL), 2 mg/10 mL (0.2 mg/mL)

Reference Brands: Oncovin®(US)

Category: Oncology Cancer Care

Vincristine Sulphate Injection is a chemotherapy drug used to treat cancers like leukemia, lymphoma, and neuroblastoma. Available in the US as Oncovin® and in the EU under various brands like Vincristine Ebewe, it works by inhibiting cell division. Ideal for B2B pharmaceutical companies seeking to enhance their oncology portfolio. Vincristine Sulphate Injection is available in Injection and strengths such as 1 mg/10 mL (0.1 mg/mL), 2 mg/10 mL (0.2 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vincristine Sulphate Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Vincristine Sulphate Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Vincristine Sulphate Injection is a chemotherapy medication used in the treatment of various cancers, including leukemia, lymphoma, neuroblastoma, and Wilms tumor. As a mitotic inhibitor, vincristine works by disrupting cell division, preventing cancer cells from growing and multiplying. In the US, it is marketed under the brand name Oncovin® and is available in various strengths for intravenous administration. In the EU, it is marketed under several brand names, including Vincristine Ebewe. Ideal for B2B pharmaceutical companies looking to expand their oncology product portfolio, this injection is crucial for combination therapy in cancer management globally.